Explaining Hormone-Deprivation Therapy Failure in Prostate Cancer Patients

Expert Review of Endocrinology and Metabolism - United Kingdom
doi 10.1586/17446651.4.2.103
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Androgen Deprivation Therapy for Prostate Cancer

2017English

Androgen Deprivation Therapy as Backbone Therapy in the Management of Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Evolving Use of Androgen Deprivation Therapy in Prostate Cancer Management

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Which Patients With Prostate Cancer Are Actually Candidates for Hormone Therapy?

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2004English

Risk of Ischemic Stroke in Patients With Prostate Cancer Receiving Androgen Deprivation Therapy in Taiwan

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Effects of Androgen-Deprivation Therapy on Hypercoagulability in Prostate Cancer Patients: A Prospective, Longitudinal Study

Canadian Urological Association Journal
Urology
2017English

Prevalence of Diabetes Mellitus and Metabolic Syndrome in Prostate Cancer Patients Given Androgen Deprivation Therapy

Journal of the ASEAN Federation of Endocrine Societies
EndocrinologyMetabolismDiabetes
2014English

Androgen Deprivation Therapy in Nonmetastatic Prostate Cancer Patients: Indications, Treatment Effects, and New Predictive Biomarkers

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Use of Androgen Deprivation Therapy in Prostate Cancer: Indications and Prevalence

Asian Journal of Andrology
MedicineUrology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy